House panel rejects prescription-drug pricing plan in setback to Biden

House panel rejects prescription-drug pricing plan in setback to Biden
·5 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

A House committee dealt an ominous if symbolic blow Wednesday to President Joe Biden’s huge social and environment package, derailing a money-saving plan to let Medicare negotiate the price it pays for prescription drugs.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting